| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Eyeglasses | 94 | 100% | |
| Sunglasses | 22 | 23% | |
| Ophthalmic Examination | 19 | 20% | |
| Visual Evoked Potential VEP | 14 | 15% | |
| Not Driving | 13 | 14% | |
| IV Steroids Infusion | 6 | 6% | |
| MRI | 6 | 6% | |
| MRI Brain | 6 | 6% | |
| Tinted Lenses | 5 | 5% | |
| Lumbar Puncture | 4 | 4% | |
| Magnifying glass | 4 | 4% | |
| Eye Drops | 3 | 3% | |
| Glatiramer acetate | 3 | 3% | |
| Interferon beta-1b SubQ Injection | 3 | 3% | |
| Cannabis | 2 | 2% | |
| Eye Patch | 2 | 2% | |
| Methylprednisolone | 2 | 2% | |
| Systane Eye Drops | 2 | 2% | |
| Bilberry | 1 | 1% | |
| Corticosteroids | 1 | 1% | |
| Counseling | 1 | 1% | |
| CT Scan Head | 1 | 1% | |
| Diclofenac Sodium | 1 | 1% | |
| Flaxseed Omega 3-6-9 | 1 | 1% | |
| Heat avoidance | 1 | 1% | |
| Interferon beta 1a IM Injection | 1 | 1% | |
| Interferon beta-1a SubQ injection | 1 | 1% | |
| Memantine | 1 | 1% | |
| MRI Cervical Spine | 1 | 1% | |
| Natalizumab | 1 | 1% | |
| Neuropsychological testing | 1 | 1% | |
| Optical Coherence Tomography OCT | 1 | 1% | |
| Stress reduction | 1 | 1% | |
| Ultrasound Eyes | 1 | 1% |